Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice

Journal of Endotoxin Research

Volumn 9, Issue 6, 2003, Pages 341-347

  Lanza Jacoby, Susan ^a,b   Miller, Sheldon ^a,b   Jacob, Shushan ^a,b   Heumann, Didier ^a,b   Minchenko, Alexander G ^a,b   Flynn, John T ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIVER ANTIGEN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENDOTOXEMIA; GRAM NEGATIVE INFECTION; HYPERLIPOPROTEINEMIA; IMMUNE RESPONSE; IMMUNITY; INFECTION SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; LIVER LEVEL; MALE; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROVOCATION TEST; PUNCTURE; SEPSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; WILD TYPE;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; BLOTTING, WESTERN; CHOLESTEROL; DISEASE SUSCEPTIBILITY; HYPERLIPOPROTEINEMIAS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; RNA, MESSENGER; SEPSIS; SERUM ALBUMIN; SERUM AMYLOID A PROTEIN; TIME FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0346398236     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225002782     Document Type: Article

References (29)

1. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86: 696-702.
2. Harris HW, Grunfeld C, Feingold KR et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-1034.
3. Read TE, Grunfeld C, Kumwenda Z et al. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery 1995; 117: 62-67.
4. Read TE, Grunfeld C, Kumwenda Z et al. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med 1995; 182: 267-272.
5. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin A. In vivo protection against endotoxin by plasma high-density lipoproteins.. Proc Natl Acad Sci USA 1993; 90: 12040-12044.
6. Netea MG, Demacker NM, Kullberg BJ et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe Gram-negative infections. J Clin Invest 1996; 97: 1366-1372.
7. Vreugdenhil ACE, Snoek AMP, van't Veer C, Greve J-WM, Buurman WA. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interactions. J Clin Invest 2001; 107: 225-234.
8. -/- mice have increased mortality after endotoxin challenge. FASEB J 1999; 13: 983.
9. deBont N, Netea MG, Denmacker PN et al. Apolipoprotein E knockout mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipids Res 1999; 40: 680-685.
10. Roselaar SE, Daugherty A. Apoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 1998; 39: 1740-1743.
11. Rensen PCN, Oosten M, van de Bilt E, van Eck M, Kuiper J, van Berkel TJC. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 1997; 99: 2438-2445.
12. Oosten MV, Rensen PCN, Van Amersfoort ES et al. Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. J Biol Chem 2001; 276: 8820-8824.
13. Netea MG, Demacker NM, deBont N et al. Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low density-deficient mice. Infect Immun 1997; 65: 2663-2667.
14. Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun 1993; 61: 2741-2747.
15. Wichterman KA, Bane AE, Chaudry IH. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980; 29: 189-201.
16. Le Roy D, Di Padova F, Tees R et al. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or presentation of LPS/LBP complexes to CD14. J Immunol 1999; 162: 7454-7460.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
18. Setoguchi M, Nasu N, Yoshida S. Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim Biophys Acta 1989; 1008: 213-222.
19. Lengacher S, Jongeneel CV, Le Roy D et al. Reactivity of murine and human recombinant LPS-binding protein (LBP) with LPS and Gram-negative bacteria. J Inflamm 1996; 47: 165-172.
20. Raynal F, Michot B, Bachellerie JP. Complete nucleotide sequence of mouse 18S rRNA gene: comparison with other available homologs. FEBS Lett 1984; 167: 263-268.
21. Gallay P, Heumann D, LeRoy D, Barras C, Glauser MP. Lipopolysaccharide-binding protein as a major protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 1993; 90: 9935-9938.
22. McAdam KPWJ, Sipe JD. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins; and casein. J Exp Med 1976; 144: 1121-1127.
23. Marchant A, Duchow J, Delville JP, Goldman M. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur J Immunol 1992; 60: 1663-1665.
24. Schumann RR. Mechanisms of transcriptional activation of lipopolysaccharide binding protein (LBP). Prog Clin Biol Res 1995; 392: 297-304.
25. Wang SC, Klein RD, Wahl WL et al. Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis. J Surg Res 1998; 76: 67-73.
26. McMasters KM, Peyton JC, Hadjiminas DJ, Cheadle WG. Endotoxin and tumor necrosis factor do not cause mortality from cecal ligation and puncture. Cytokine 1994; 6: 530-536.
27. Dofferhoff A, Hbom V, de Vries-Hospers H et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-192.
28. Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a parenteral nutrition formulation containing lipid emulsion. J Parenter Enteral Nutr 1986; 10: 494-497.
29. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11: 443-451.